国产自慰在线观看,无码乱人伦一区二区亚洲第一,找av综合福利,人人草人人
join us
CN
Home page
About Us
Profile
Affiliates/Subsidiaries
Development History
Quality Management
Contact Us
Legal Statement
Adverse Reaction Report
Science and Technology
R&D platform
R&D pipeline
Therapeutic Field
International Business
APIs
Finished Products
Medical device
Download product list
Contact
News Center
News & Trends
Public information
News & Trends
31
2024-07
SAL0120 tablets for treatment of chronic kidney disease(CKD) approved for clinical trial
05
2024-07
Innovative type 2 diabetes drug Fultagliptin benzoate tablet (Xinliting) obtained marketing authorization
21
2024-05
The new anti-hypertension drug “Allisartan and Amlodipine tablets” (FoLitan?) approved for market
07
2024-04
JK07 for the treatment of chronic heart failure in adults was approved for Phase II clinical trial in China Abstract: A Phase II clinical trial in adults with chronic heart failure (RENEU-HF) was initiated
14
2023-12
Salubris' innovative drugs Allisartan and Enarodustat? were enrolled into 2023 National Reimbursement Drug List(NRDL)
10
2023-10
New overseas clinical progress of JK07 for the treatment of chronic heart failure (HFrEF)
目前在第
2
頁,
共有
10
頁,
共有
60
條記錄
第一頁
上一頁
1
2
3
4
5
下一頁
最后一頁
跳轉(zhuǎn)到
頁